2m 2m 2m 2m 2m 2m 2m
MAPLIGHT THERAPE (MPLT)
NASDAQ
$36.57$0.00 (0.00%)
Price as of Jul 14, 2026 8:10 AM EDT- $1.6BMarket Cap
- N/A1-Year Change
- BiotechnologyIndustry
MAPLIGHT THERAPE (MPLT)
$36.57$0.00 (0.00%)
MPLT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $36.57 | ||
Change | -$2.75 (-6.99%) | ||
Open | $38.46 | ||
High | $39.28 | ||
Low | $35.63 | ||
Previous Close | $39.32 | ||
Volume | 511,545 | ||
30-Day Average Volume | 558,449 | ||
1-Week Change | 4.37% | ||
1-Month Change | 31.78% | ||
1-Year Change | N/A | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 42.6M | ||
Total Assets | $418.8M | ||
Market Cap | $1.6B | ||
Enterprise Value | $1.5B | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$60.7M | ||
Free Cash Flow | -$51.2M | ||
EBIT | -$60.7M | ||
EBITDA | -$60.5M | ||
Net Working Capital | N/A | ||
EPS | -$1.34 | ||
Enterprise Value/EBITDA | -25 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 4 | ||
P/E | -27 | ||
PEG | -0 | ||
Price/Free Cash Flow | -30 | ||
Price/Operating Cash Flow | -30 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue